Compare Stocks: CAH vs. MCK vs. WGRX vs. YI

Market Snapshot

Current market context for the selected companies.

CAH

$238.08

Market Cap $55.33B

Sector Healthcare

Industry Healthcare Distribution

Data through 2026-08-26

MCK

$896.87

Market Cap $105.52B

Sector Healthcare

Industry Medical Distribution

Data through 2026-08-26

WGRX

$3.03

Market Cap $182.88M

Sector Healthcare

Industry Medical Distribution

Data through 2026-07-29

YI

$3.47

Market Cap 33.44M

Sector Healthcare

Industry Medical Distribution

Data through 2026-08-26

Performance

Absolute returns and relative performance versus SPY.

Metric	CAH	MCK	WGRX	YI
1 Month	+2.4%	+0.8%	+3.4%	-12.2%
1 Month vs SPY	-0.9%	-2.5%	+0.1%	-15.5%
3 Months	+19.1%	+18.6%	-47.3%	-35.7%
3 Months vs SPY	+17.1%	+16.6%	-49.3%	-37.7%
6 Months	+5.3%	-6.9%	-84.6%	-58.1%
6 Months vs SPY	-5.2%	-17.3%	-95.0%	-68.6%
1 Year	+63.0%	+32.1%	-93.9%	-51.0%
1 Year vs SPY	+43.9%	+13.0%	-113.0%	-70.1%
2 Years	+117.1%	+60.7%	—	+273.1%
2 Years vs SPY	+80.6%	+24.1%	—	+236.6%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	CAH	MCK	WGRX	YI
Revenue Growth	5.8%	7.7%	-85.6%	-33.1%
Earnings Growth	68.8%	-17.6%	—	—
Gross Margin	3.8%	3.6%	-49.5%	3.0%
Operating Margin	1.3%	1.3%	-385.7%	-0.8%
Net Margin	0.7%	1.1%	0.0%	-0.8%
Return on Equity	—	—	—	-14.8%
Return on Assets	3.7%	4.7%	-79.2%	-0.6%

Valuation

Common valuation multiples shown side by side.

Metric	CAH	MCK	WGRX	YI
P / E	32.9	24.3	—	-187.6
Forward P / E	16.9	18.1	—	27.1
P / S	0.2	0.3	13.0	0.0
P / B	-20.9	-27.7	-0.5	—
EV / Sales	0.2	0.3	2.7	0.1
EV / EBIT	17.5	20.1	-0.7	—
P / FCF	11.6	15.5	-27.1	—
FCF Yield	8.6%	6.4%	-3.7%	—

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	CAH	MCK	WGRX	YI
Free Cash Flow	$4.75B	$6.80B	-$6.76M	-80.00M
Operating Cash Flow	$5.17B	$6.85B	-$12.92M	-85.18M
Debt / Equity	—	—	—	150.9%

Earnings Outlook

Upcoming earnings expectations when available.

Metric	CAH	MCK	WGRX	YI
Next Earnings	2026-11-05	2026-11-04	—	—
EPS Estimate	2.94	10.77	—	—
Revenue Estimate	66.67B	109.93B	—	—
EPS Growth	+41.2%	+9.2%	—	—
Revenue Growth	+4.2%	+6.6%	—	—
Analyst Coverage	15	15	—	—